A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Manufactured by
Applied Biocode, Inc.
United States
Applied BioCode is a leading IVD manufacturer driving advances in multiplex molecular diagnostics for clinical and reference laboratories. Its proprietary Barcoded Magnetic Beads (BMB) technology combines digital barcoding with molecular chemistry to deliver high-throughput, highly accurate detection of multiplex panel targets on a single platform. Applied BioCode delivers flexible, high-throughput solutions on the BioCode MDx-3000 system, featuring FDA-cleared 17-plex respiratory and gastrointestinal panels, SARS-CoV-2 Flu plus RSV combination assays, and RUO panels targeting fungal pathogens and sexually transmitted infections with antimicrobial resistance markers. These solutions help laboratories streamline workflows, expand testing menus, and maximize efficiency.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
KogeneBiotech Co., Ltd.
South Korea · 2 relevant products
SeeGene Middle East FZE
South Korea · 2 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 4 relevant products
59 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 115 closest product alternatives
KogeneBiotech Co., Ltd. · South Korea
Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.
SeeGene Middle East FZE · South Korea
A multiplex diagnostic assay for the simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus. This assay is part of the Allplex™ product line for comprehensive respiratory infection testing.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.
112 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products